https://www.selleckchem.com/pr....oducts/elsubrutinib.
To determine rates of psychiatric comorbidity in a clinical sample of childhood movement disorders (MDs). Cohort study. Tertiary children's hospital MD clinics in Sydney, Australia and London, UK. Cases were children with tic MDs (n=158) and non-tic MDs (n=102), including 66 children with dystonia. Comparison was made with emergency department controls (n=10, neurology controls with peripheral neuropathy or epilepsy (n=37), and community controls (n=10 438). On-line development and well-being assessment which was additionally cli
Aimer
Commentaire
Partagez
